Warburg Pincus will acquire Everise, a leading global healthcare services outsourcing company, from its existing investor Brookfield, said a company press release. Warburg Pincus’ investment values the company at around $1 billion and Brookfield will retain a minority stake. Further details of the stake buyout is not disclosed.
Warburg Pincus is in advanced negotiations to acquire Everise Holdings, a Delaware-registered outsourcing company, ET first reported on 28 July. ET first reported in May on Warburg Pincus' interest in Everise.
Headquartered in the US, with over 19,000 employees in eight markets, Everise provides customer service solutions to some of the world’s leading healthcare companies. As part of the transaction, Everstone Group, the Singapore-headquartered private equity firm will exit its investment in Everise, said the release.
Other investors who were in discussion include Accenture, Teleperformance and Veritas Capital, ET reported.
“Everise extends a vast array of top-tier services to its clients, including some of the world's largest healthcare organizations. We are excited about backing Everise’s exceptionally experienced leadership team that has a proven track record of driving scale and profitability. With our deep network and resources across Asia and the US, we are well-positioned to help Everise gain further momentum as a leader in the industry,” said Saurabh Agarwal, Managing Director of Warburg Pincus.
In 2016, PE fund Everstone had partnered with Sunrise BPO to launch Everise and expanded the business through multiple buyouts. Brookfield acquired Everise from Everstone in 2020 in a deal worth $450